Screener
MIRA Pharmaceuticals, Inc. MIRA Q2 2025 earnings
Reported August 14, 2025 · Before market open
EPS-$0.09Beat by $0.02
EPS estimate-$0.11
Next report
Dec 2, 2026 (in 2 months)EPS estimate-$0.03
Versus estimates
Diluted EPS
Q2 2026-$0.03Q1 2026-$0.03Q4 2025-$0.15Miss by $0.11Q3 2025-$1.18In line
Q2 2025-$0.09Beat by $0.02
Q1 2025-$0.11Beat by $0.04FAQ
- When did MIRA Pharmaceuticals, Inc. report Q2 2025 earnings?
- MIRA Pharmaceuticals, Inc. (MIRA) reported Q2 2025 earnings on August 14, 2025 before market open.
- What were MIRA Pharmaceuticals, Inc.'s Q2 2025 revenue and EPS?
- MIRA Pharmaceuticals, Inc. reported eps of $-0.09 for Q2 2025.
- Did MIRA Pharmaceuticals, Inc. beat estimates in Q2 2025?
- EPS beat the consensus estimate of $-0.11 by $0.02.
- How did MIRA Pharmaceuticals, Inc.'s Q2 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 18.2% from $-0.11.
- Where can I find MIRA Pharmaceuticals, Inc.'s Q2 2025 SEC filings?
- You can read the 8-K earnings release (0001641172-25-023110) and the 10-Q periodic report (0001641172-25-024077) directly on SEC EDGAR. The filing index links above go to sec.gov.
